See up to 3 months of KURA. The 7-day demo opens the 1M and 3M ranges and puts KURA on your watchlist.
Start 7-day demoLatest KURA insider trades
Teresa Brophy Bair - OfficerOpen-market sale$89K
Kathleen Ford - OfficerOpen-market sale$72K- Kathleen Ford - OfficerOpen-market sale$39K
- Mollie Leoni - OfficerOpen-market sale$131K
- Mollie Leoni - OfficerOpen-market sale$310K
Thomas James Doyle - OfficerOpen-market sale$48K- Brian T. Powl - OfficerOpen-market sale$95K
- Brian T. Powl - OfficerOpen-market sale$84K
About Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. is an SEC registrant, filing under CIK 0001422143, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
KURA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 200,000 | $2.35M |
| Open-market sale | 12 | 153,881 | $1.71M |
| Grant or award | 1 | 450,000 | |
| Option exercise | 2 | 60,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KURA insider transactions (Form 4)
4656 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Teresa Brophy Bair - Officer | Open-market sale | Common Stock | 8,442 | $10.50 | $89K | |
| Kathleen Ford - Officer | Open-market sale | Common Stock | 6,906 | $10.50 | $72K | |
| Kathleen Ford - Officer | Open-market sale | Common Stock | 3,668 | $10.75 footnote F3 | $39K | |
| ||||||
| Mollie Leoni - Officer | Open-market sale | Common Stock | 12,448 | $10.50 | $131K | |
| Mollie Leoni - Officer | Open-market sale | Common Stock | 28,802 | $10.75 footnote F3 | $310K | |
| ||||||
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 4,607 | $10.50 | $48K | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 9,020 | $10.50 | $95K | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 8,000 | $10.56 footnote F3 | $84K | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 15,430 | $10.75 footnote F5 | $166K | |
| ||||||
| Francis Burrows - Officer | Option exercise | Common Stock | 30,000 | $6.15 | $185K | |
| Francis Burrows - Officer | Open-market sale | Common Stock | 20,726 | $10.83 footnote F3 | $225K | |
| Francis Burrows - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| ||||||
 Jennifer Fulk - Officer | Grant or award | Option to purchase common stock | 450,000 | $0.00 | - | |
| Troy Edward Wilson - Officer | Open-market purchase | Common Stock | 100,000 | $12.39 footnote F1 | $1.24M | |
| ||||||
| Brian T. Powl - Officer | Open-market sale | Common Stock | 4,345 | $11.89 footnote F2 | $52K | |
| ||||||
| Teresa Brophy Bair - Officer | Open-market sale | Common Stock | 31,487 | $12.63 footnote F2 | $398K | |
| ||||||
| Troy Edward Wilson - Officer | Open-market purchase | Common Stock | 100,000 | $11.12 footnote F1 | $1.11M | |
| ||||||
| Mollie Leoni - Officer | Open-market sale | Common Stock | 84,929 | $9.82 footnote F2 | $834K | |
| ||||||
| Diane L. Parks | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Michael Vasconcelles | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Faheem Hasnain | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Helen Louise Collins | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Carol Schafer | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
 Mary T. Szela | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Thomas Malley | Grant or award | Option to purchase common stock | 35,000 | $0.00 | - | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 10,000 | $11.00 | $110K | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 339 footnote F2 | $9.21 | $3K | |
| ||||||
| Kathleen Ford - Officer | Open-market sale | Common Stock | 2,257 footnote F2 | $9.08 footnote F3 | $20K | |
| ||||||
| Teresa Brophy Bair - Officer | Open-market sale | Common Stock | 2,256 footnote F2 | $9.38 footnote F3 | $21K | |
| ||||||
| Troy Edward Wilson - Officer | Option exercise | Common Stock | 6,103 | $6.15 | $38K | |
| Troy Edward Wilson - Officer | Option exercise | Stock Option (Right to Buy) | 6,103 | $0.00 | - | |
| Thomas Malley | Option exercise | Common Stock | 10,000 | $3.12 | $31K | |
| Thomas Malley | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 4,842 | $8.46 | $41K | |
| Brian T. Powl - Officer | Open-market sale | Common Stock | 1,572 | $8.46 | $13K | |
| Kathleen Ford - Officer | Open-market sale | Common Stock | 1,813 | $8.46 | $15K | |
| Mollie Leoni - Officer | Open-market sale | Common Stock | 3,655 | $8.46 | $31K | |
| Mollie Leoni - Officer | Open-market sale | Common Stock | 2,233 | $8.46 | $19K | |
| Mollie Leoni - Officer | Open-market sale | Common Stock | 951 | $8.46 | $8K | |
| Mollie Leoni - Officer | Open-market sale | Common Stock | 1,341 | $8.46 | $11K | |
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 2,226 | $8.46 | $19K | |
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 2,226 | $8.46 | $19K | |
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 1,114 | $8.46 | $9K | |
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 695 | $8.46 | $6K | |
| Thomas James Doyle - Officer | Open-market sale | Common Stock | 881 | $8.46 | $7K | |
| Francis Burrows - Officer | Open-market sale | Common Stock | 1,311 | $8.46 | $11K | |
Item 8.01
Item 5.02
Item 2.02, 9.01
Item 5.02
Item 5.02, 5.07, 9.01
Recent KURA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| BRIAN POWL | Officer | 15,430 | $164K | View on EDGAR | |
| MOLLIE LEONI | Officer | 28,802 | $306K | View on EDGAR | |
| KATHLEEN FORD | Officer | 3,668 | $39K | View on EDGAR |
KURA insider trading FAQ
What is the latest insider trade for KURA?
Kura Oncology, Inc. (KURA) had 11 insider filings in the last 90 days, with the most recent on 2026-09-29. The full record for KURA runs to 56 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KURA stock?
2 insider purchases of KURA were filed in the last 90 days, totaling $2.35M.
How many insiders are selling KURA stock?
12 insider sales of KURA were filed in the last 90 days, totaling $1.71M.
Where can I see KURA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KURA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Teresa Brophy Bair view on EDGAR
- - Kathleen Ford view on EDGAR
- - Mollie Leoni view on EDGAR
- - Thomas James Doyle view on EDGAR
- - Brian T. Powl view on EDGAR
- - Francis Burrows view on EDGAR
- - Jennifer Fulk view on EDGAR
- - Troy Edward Wilson view on EDGAR
- - Brian T. Powl view on EDGAR
- - Teresa Brophy Bair view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where KURA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KURA with a 7-day demo
- KURA on your watchlist
- Every KURA Form 4 filing on record
- Up to 3 months of KURA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.